Tremfya 200 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F03B0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,938
Award facts
- Contract value 100% obligated
- $22,937.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 12, 2026, the Defense Logistics Agency awarded a delivery order valued at $22,937.79 to AmerisourceBergen Drug Corp for the supply of TREMFYA 200 mg/2 mL pen injections. The contract is firm fixed-price with no set-aside designation, reflecting open competition. Performance will be completed by February 3, 2026, with fulfillment based at the company's corporate office in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government agencies. The parent company holds a significant IDC with the Defense Logistics Agency valued at $999,999,999.00 through December 31, 2031, and has established itself as a critical vendor for military and veteran healthcare systems through competitively awarded contracts. These overarching contracts enable efficient procurement of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26F03B0?
SPE2DR26F03B0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F03B0 worth?
The government has obligated $22,938 on SPE2DR26F03B0.
Is contract SPE2DR26F03B0 an order under another contract?
Yes. SPE2DR26F03B0 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F03B0 competed?
The extent of competition for SPE2DR26F03B0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award